International Journal of Peptide Research and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 28.6% | 0.532 | Q2 | 63.2% |
| 2024 | 2.4 | Q3 | 29.4% | 0.449 | Q3 | 58.6% |
| 2023 | 2.0 | Q4 | 28.4% | 0.433 | Q3 | 60.3% |
| 2022 | 2.5 | Q4 | 27.0% | 0.395 | Q3 | 58.9% |
| 2021 | 2.2 | Q4 | 31.1% | 0.365 | Q3 | 57.5% |
| 2020 | — | — | 0.304 | Q3 | 50.9% | |
| 2019 | — | — | 0.264 | Q3 | 48.2% | |
| 2018 | — | — | 0.284 | Q3 | 48.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1573-3904
ISSN
1573-3149
region
Western Europe
coverage
1996-2002, 2005-2026